Sanofi Launches Generic Arava

Sanofi Launches Generic Arava
Sanofi Launches Generic Arava

Sanofi announced the launch of leflunomide Tablets, the generic version of its Arava, through the company's generic division Winthrop US.

Arava is a pyrimidine synthesis inhibitor indicated for active rheumatoid arthritis to reduce signs/symptoms, inhibit structural damage, and improve physical function. It may be used with aspirin, NSAIDs, and/or low-dose corticosteroids.

RELATED: Chart: Arthritis Treatments: DMARDS and Other Immune Modulators

Leflunomide Tablets are available in 10mg and 20mg strengths in 30-count bottles and in 100mg 3-count blister packs.

For more information visit Sanofi.us.

Loading links....